Fluorescent dye may help spot date-rape drug in drinks - 8 News NOW

Fluorescent dye may help spot date-rape drug in drinks

Updated:
© iStockphoto.com / Thinkstock © iStockphoto.com / Thinkstock

MONDAY, March 31, 2014 (HealthDay News) -- Researchers say they've developed a simple new test that quickly detects the date-rape drug GHB in drinks.

GHB (gamma-hydroxybutyric acid), a central nervous system depressant, is one of the most commonly used date-rape drugs. Spiking drinks with GHB, which is odorless and colorless, incapacitates victims, making them vulnerable to sexual assault.

When the fluorescent compound is mixed with a sample of drink containing GHB, the mixture changes color in less than 30 seconds, according to the research team at the National University of Singapore.

The researchers tested a number of fluorescent compounds with a wide range of GHB concentrations and identified one called GHB Orange that changes color when mixed with the date-rape drug.

The team then tested the ability of GHB Orange to detect GHB in different types of alcoholic and non-alcoholic drinks and found that it was effective, according to the study, published recently in the journal Chemical Communications.

The color change was readily apparent in clear and light-colored drinks such as water or vodka, but additional lighting was needed to detect the change in darker drinks such as cola and whiskey, the researchers said.

More information

The U.S. Office on Women's Health has more about date rape drugs.

Copyright © 2014 HealthDay. All rights reserved.

  • Paula's Health NotesLas Vegas Health NewsMore>>

  • Prostate frozen lumpectomy offers patients an alternative

    Prostate frozen lumpectomy offers patients an alternative

    Tuesday, July 29 2014 3:39 PM EDT2014-07-29 19:39:02 GMT
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
  • New therapies for epilepsy

    New therapies for epilepsy

    Friday, July 25 2014 3:00 PM EDT2014-07-25 19:00:14 GMT
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
  • Study touts health care workers with less than bachelor's degree

    Study touts health care workers with less than bachelor's degree

    Thursday, July 24 2014 12:08 AM EDT2014-07-24 04:08:05 GMT
    Among Las Vegas workers with less than a bachelor’s degree only 3.5 percent hold jobs in the most common health care occupations, the lowest percentage among the nation’s 100 largest metropolitan areas, the Brookings Institution reported Wednesday night.More>>
    Among Las Vegas workers with less than a bachelor’s degree only 3.5 percent hold jobs in the most common health care occupations, the lowest percentage among the nation’s 100 largest metropolitan areas, the Brookings Institution reported Wednesday night.More>>
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KLAS. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.